Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe revision tag on the page has been updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange Detected- Revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a glossary section and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed or adjusted. These changes do not affect the study details, eligibility criteria, or primary outcomes — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check72 days agoChange DetectedRevision note updated from v3.3.3 to v3.3.4; no substantive study information appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.